At the genetic level, sporadic MTC is caused by a germline mutation in the RET proto-oncogene in 30–50% of cases, whereas PTC is primarily linked to somatic mutations in the BRAFV600E gene. This evidence concerns the gene RET and medullary thyroid gland carcinoma.